Skip to main content
. 2022 Dec 15;23:347. doi: 10.1186/s12931-022-02268-3

Fig. 1.

Fig. 1

PRISMA flowchart. COPD chronic obstructive pulmonary disease, LABA long-acting beta-2 agonists, LAMA long-acting muscarinic antagonists, PRISMA Preferred Reporting Items for Systematic Reviews and Meta-analyses Statement